Related Experiment Video
Updated: Apr 4, 2026

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
[Optimization strategies in management of CMV infection in transplant patients]
1David Navarro, Servicio de Microbiología, Hospital Clínico Universitario de Valencia, Fundación INCLIVA y Departamento de Microbiología de la Universitat de Valencia, Spain. david.navarro@uv.es.
Abstract:
Currently, two therapeutic strategies are applied for preventing the development of CMV end-organ disease in transplant recipients: universal prophylaxis and preemptive antiviral therapy. Both are potentially optimable. As for the former strategy, precisely identifying patients at greatest risk of viremia would allow for a targeted prophylaxis. In this sense several genotypic, immunological and biological markers have been described that could be ancillary to that purpose. As for the latter strategy, combined monitoring of plasma CMV DNA load and peripheral levels of CMV-specific CD8 + and CD4 + IFN-γ producing T cells would permit a more rationale use of antivirals, thus avoiding overtreatment and derived toxicity.
More Related Videos
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
11:18Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
Published on: May 7, 2012
Related Concept Videos
Cytomegalovirus Disease
Kidney Transplant III: Nursing Management
Cystic Fibrosis: Management
Sinus disease and chronic...
Myocarditis III: Medical Management
Retrovirus Life Cycles
Inhibitors of Viral Protein Synthesis